| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Oral dermatological agent allergy |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Allergy to gamolenic acid (finding) |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Allergy to retinoid (finding) |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Allergy to etretinate |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Allergy to acitretin (finding) |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Allergy to tretinoin (finding) |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Allergy to isotretinoin |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Overdose of drug groups and agents primarily acting on the skin |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Topical dermatological preparation overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Oral dermatological agent overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Gamolenic acid overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Accidental gamolenic acid overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Intentional gamolenic acid overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Gamolenic acid overdose of undetermined intent |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Retinoid overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Etretinate overdose (disorder) |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Accidental etretinate overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Intentional etretinate overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Acitretin overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Accidental acitretin overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Intentional acitretin overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| surdose d'acitrétine d'intention indéterminée |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Tretinoin overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Accidental tretinoin overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Intentional tretinoin overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| surdose de trétinoïne d'intention indéterminée |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Isotretinoin overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Accidental isotretinoin overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Intentional isotretinoin overdose |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| surdose d'isotrétinoïne d'intention indéterminée |
Causative agent (attribute) |
False |
agent cutané |
Inferred relationship |
Some |
|
| Hair treatment medication |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Rectal soothing preparations |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Bismuth subgallate compound suppository BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Hamamelis 200mg suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Hamamelis + zinc oxide suppository |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Local sclerosants |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| tétradécylsulfate de sodium 0,2 %, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Tretinoin [cytostatic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Tretinoin 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Kaolin poultice BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Methyl salicylate liniment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Methyl salicylate ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Turpentine liniment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| White liniment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Capsaicin 750 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Diethylamine salicylate 10% cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Capsaicin 250 microgram/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Zinc sulfate 2.5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Zinc sulfate+epinephrine eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Aluminum acetate [ear] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Aluminum acetate 13% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Aluminum acetate 8% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Sodium bicarbonate ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Almond+arachis+camphor oil compound drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Docusate sodium 5 mg/mL ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Docusate sodium 50 mg/mL ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Chlorbutol+dichlorobenz+arachis oil 5%/2%/57% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Urea-hydrogen peroxide complex 5% ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Compound thymol glycerin solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Artificial saliva compound spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Gastric mucin 3.5% (porcine) spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Mucin 63 mg and xylitol 39 mg oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Zinc compound paste BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Zinc 32% cream BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Zinc 15% ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Zinc+castor oil ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Dusting powders |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Talc dusting powder BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Zinc+starch+talc dusting powder BPC |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Topical form antihistamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely diphenhydramine hydrochloride 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely benzocaine 20 milligram/1 gram and mepyramine maleate 20 milligram/1 gram conventional release cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely mepyramine maleate 20 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Doxepin hydrochloride [antipruritic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Doxepin hydrochloride 50 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Preparations for psoriasis+eczema |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Calamine+coal tar ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Coal tar+salicylic acid ointment BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Coal tar 10% paint |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Coal tar 7.5% paste BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Zinc+coal tar paste BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Coal tar ointment BPC |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Strong coal tar 40% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Coal tar 10 mg/mL cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Coal tar 40% bath emulsion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely coal tar 60 milligram/1 milliliter and lecithin 4 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Strong coal tar solution+pine tar 5/5% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Coal tar 10 mg/mL cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Coal tar solution 10% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Allantoin 20 mg/g and coal tar extract 50 mg/g cutaneous lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Coal tar 20% solution BP |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing bufexamac (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely calcipotriol 50 microgram/1 milliliter conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Calcipotriene 50micrograms/mL scalp solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Acitretin 10 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Acitretin 25 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing tacalcitol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Product containing precisely tacalcitol (as tacalcitol monohydrate) 4 microgram/1 gram conventional release cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
| Coal Tar [2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
agent cutané |
Inferred relationship |
Some |
|
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]